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Mutations in LTBP4 Cause a Syndrome of Impaired
Pulmonary, Gastrointestinal, Genitourinary,
Musculoskeletal, and Dermal Development
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Jiwon Choi,6 Carla Sens,1 Chester W. Brown,7,8 Robin D. Clark,9 Kristen E. Holland,10
Michael Marble,11,12 Lynn Y. Sakai,13 Branka Dabovic,4 Daniel B. Rifkin,4,5 and Elaine C. Davis6
We report recessive mutations in the gene for the latent transforming growth factor-b binding protein 4 (LTBP4) in four unrelated
patients with a human syndrome disrupting pulmonary, gastrointestinal, urinary, musculoskeletal, craniofacial, and dermal develop-
ment. All patients had severe respiratory distress, with cystic and atelectatic changes in the lungs complicated by tracheomalacia and
diaphragmatic hernia. Three of the four patients died of respiratory failure. Cardiovascular lesions were mild, limited to pulmonary
artery stenosis and patent foramen ovale. Gastrointestinal malformations included diverticulosis, enlargement, tortuosity, and stenosis
at various levels of the intestinal tract. The urinary tract was affected by diverticulosis and hydronephrosis. Joint laxity and low muscle
tone contributed to musculoskeletal problems compounded by postnatal growth delay. Craniofacial features included microretrogna-
thia, ﬂat midface, receding forehead, and wide fontanelles. All patients had cutis laxa. Four of the ﬁve identiﬁed LTBP4 mutations led
to premature termination of translation and destabilization of the LTBP4 mRNA. Impaired synthesis and lack of deposition of LTBP4
into the extracellular matrix (ECM) caused increased transforming growth factor-b (TGF-b) activity in cultured ﬁbroblasts and defective
elastic ﬁber assembly in all tissues affected by the disease. These molecular defects were associated with blocked alveolarization and
airway collapse in the lung. Our results show that coupling of TGF-b signaling and ECM assembly is essential for proper development
and is achieved in multiple human organ systems by multifunctional proteins such as LTBP4.Introduction
The transforming growth factor betas (TGF-bs) compose
a family of cytokines critical for regulatingmultiple cellular
processes, including proliferation, differentiation, migra-
tion, and death.1 TGF-bs are generally secreted as a part
of a large latent complex (LLC), consisting of the growth
factor, its propeptide, and a latent TGF-b binding protein
(LTBP), linked to the propeptide via two disulﬁde bonds.2
Release of TGF-b from the LLC, referred to as TGF-b activa-
tion because it is required for the binding of the cytokine to
its receptors,3 occurs via proteolysis or integrin-mediated
displacement. Within the LLC, the noncovalent associa-
tion of the propeptide with TGF-ß confers latency, and
the LTBP is thought to direct the latent TGF-ß and propep-
tide, the small latent complex (SLC), to speciﬁc sites in the
extracellular matrix (ECM).
There are four known LTBP genes (LTBP1-4 [MIM
150390, 602091, 602090, 604710]), each yielding multiple
LTBP isoforms by dual promoter use and alternative
splicing.2 LTBP1 and LTBP3 bind all three isoforms of
TGF-b, whereas LTBP4 binds only TGF-b1.4 LTBPs share
structural homology with ﬁbrillins and target the latent
TGF-b complex to ﬁbrillin microﬁbrils that are often asso-The Americanciated with elastic ﬁbers in the ECM.2 Thus, the LTBPs may
serve as molecular modulators for the disposition of latent
TGF-b and the assembly of other matrix proteins.
Elastic ﬁbers consist of a scaffold of ﬁbrillin microﬁbrils
that surround elastin, a protein polymer of elastin precur-
sors (tropoelastin) crosslinked by lysyl oxidase enzymes.
Impaired elastic ﬁber formation leads to defective pulmo-
nary, vascular, and connective tissue development. For
example, deletions or point mutations in the elastin
gene (ELN [MIM 130160]) lead to reduced amounts of
elastin, causing supravalvular aortic stenosis either as a
part of Williams-Beuren syndrome (WBS [MIM 194050])
or as an isolated familial disease (MIM 185500). Another
class of mutations in ELN results in the synthesis and
incorporation of mutant tropoelastin into the ECM,
leading to disruption of the structure and function of
elastic ﬁbers in autosomal-dominant cutis laxa (ADCL
[MIM 123700]).5–9
In addition to structural proteins and crosslinking
enzymes, elastic ﬁber formation requires multiadhesive
adaptor proteins, such as ﬁbulin-410 and ﬁbulin-5.11,12
Mutations in FBLN4 (EFEMP2 [MIM 604633])13,14 and
FBLN5 (MIM 604580)15–17 cause autosomal-recessive cutis
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severe developmental emphysema and vascular malfor-
mations.
Recent human genetic and animal model studies have
highlighted a close coupling of TGF-b signaling and elastic
ﬁber integrity. Mutations in ﬁbrillin-1 (FBN1 [MIM
134797]) cause Marfan syndrome (MFS [MIM 154700]),18
in which structural abnormalities in microﬁbrils lead to
pathologically elevated TGF-b signaling.19 Conversely, in
Loeys-Dietz syndrome (LDS [MIM 610168, 609192]),
increased TGF-b signaling associated with TGF-b receptor
mutations (TGFBR1 [MIM 190181] and TGFBR2 [MIM
190182]) leads to impaired elastic ﬁber deposition. Further-
more, in aortic tortuosity syndrome (ATS [MIM 208050]),
SLC2A10 (MIM 606145) mutations lead to both elastic
ﬁber disruption and altered TGF-b signaling.20
Here, we describe four patients with a constellation of
lesions affecting the craniofacial, pulmonary, gastrointes-
tinal, genitourinary, musculoskeletal, and integumentary
systems and identify recessive mutations in LTBP4 as a
cause. Furthermore, we show that elevated TGF-b signaling
and disruption of the elastic ﬁbers are key molecular char-
acteristics of the disease process.
Subjects and Methods
The subjects of this study participated after giving their informed
consent. This study was approved by the Human Research Protec-
tion Ofﬁce (institutional review board) of the Washington Univer-
sity School of Medicine. Tissue samples were collected as skin
biopsies or as autopsy material. Normal control tissue samples
were provided by the Cooperative Human Tissue Network, which
is funded by the National Cancer Institute. Other investigators
may have received samples from the same subjects.
Patient 1
Patient1wasborn to second-cousinparents ofHispanic ancestry, at
a gestational age of 38.7 wks, by a Cesarean section performed after
breech presentation in an uneventful pregnancy. Length, weight,
and head circumference percentiles at birth were 64th, 40th, and
90th, respectively. Physical examination showed lax, redundant,
and inelastic skin, especially of the shoulder and neck region
(Figure 1C) and the extremities (Figure 1D). The patient had hyper-
telorism (Figure 1A), microretrognathia, and dolichocephaly
(Figure 1B). The fontanelles were large. The cheeks and the perior-
bital regionwere puffy (Figure 1A), the philtrum long, and the right
earlobe folded. The patient had widely spaced ﬁrst and second toes
(Figures 1D and 1E) and bilateral transverse plantar creases
(Figure 1E). He had a hoarse cry and a low muscle tone. Although
initial serum ceruloplasmin level was low, repeat ceruloplasmin
and copper tests performed several times showed results within
normal limits. Hair shafts were normal; no abnormal twisting or
angulation was observed.
Respiratory and feeding difﬁculties prompted detailed clinical
investigations within the ﬁrst 2 mo of life, when the patient was
in the neonatal intensive care unit. A gastrostomy tube was placed,
butweightgainandgrowthremainedslow.The length,weight, and
head circumferencepercentiles at the ageof 55dayswere 37th, 36th,
and36th, respectively. Bronchoscopy resultswerenormal, but chest
X-ray showed occasional changes consistent with pneumonia.594 The American Journal of Human Genetics 85, 593–605, NovembEchocardiography showed moderate hypoplasia of the left
pulmonary artery (pressure gradient 64 Hgmm, peak velocity
5.8 m/s), mild hypoplasia of the right pulmonary artery (pressure
gradient 4 Hgmm), and mild right ventricular hypertrophy. Heart
murmur consistent with peripheral pulmonary stenosis was also
detected. Abdominal ultrasound showed normal caliber of the
aorta and renal arteries.
Distension of the abdomen suggested gastrointestinal abnor-
malities. Subsequent X-ray images showed dilated intestinal struc-
tures (Figure 1F). Upper gastrointestinal contrast imaging demon-
strated a dilated, tortuous esophagus (Figure 1G) but neither
tracheoesophageal ﬁstula nor vascular ring. Gastroesophageal
reﬂux was absent by pH probe measurements. The second portion
of the duodenum was also tortuous. A cystogram showed severe
diverticulosis and thickened bladder wall (Figure 1H). Renal ultra-
sound revealed severe left hydronephrosis, renal cortical thin-
ning, and dilated posterior urethra. He had both inguinal
(Figure 1F) and umbilical hernias. After being discharged from
the intensive care unit, the patient was hospitalized ﬁve times
over a period of 6 mo for respiratory distress, pneumonia, and
atelectasis. Mechanical ventilation was advised against because
of the potential for barotrauma on the lung tissue. After his last
hospitalization, at 8 mo, the patient was discharged to hospice
care, and he died at home when he was 9 mo old. An autopsy
was not performed.
Patient 2
Patient 2 was born at term to unaffected and unrelated parents
of Mexican origin (Figure 2C). Birth length, weight, and head
circumference were at the 75th–90th, >90th, and 75th–90th percen-
tiles, respectively. He was noted at birth to have lax, redundant,
and inelastic skin throughout the body (Figures 1J and 1K). He
had a ﬂattened midface with a receding forehead, wide nasal
bridge, hypertelorism, long philtrum, micrognathia, and swollen
eyelids (Figure 1I). His chest was bell-shaped (Figure 1M), with
a prominent xiphoid. His ear canals were difﬁcult to visualize as
a result of his skin redundancy, and he failed the newborn hearing
screen twice. He had hyperextensible small joints and decreased
muscle tone. A wide space was also noted between his ﬁrst and
second toes, with a vertical crease on his soles starting between
the ﬁrst and second toes, extending over 2/3 of his soles. He was
referred to pediatric dermatology for his skin condition at the
age of 10 days and was diagnosed with cutis laxa. At that time,
he was thriving without respiratory or feeding difﬁculties. At
20 days, he required surgery for pyloric stenosis. During this
admission, a murmur was noted, and an echocardiogram was
performed, showing normal anatomy with a patent foramen
ovale. Because of the cutis laxa, a voiding cystourethrogram
(VCUG), skeletal survey, and skull X-ray were performed. The
VCUG demonstrated innumerable bladder diverticula of varying
sizes (Figure 1N). Aside from bilateral hindfoot varus deformity,
the skeletal survey was normal. The skull X-ray showed mandib-
ular hypoplasia and decreased mineralization with widened
cranial sutures. A hearing screen performed during this admission
was normal. He demonstrated good oral intake andwas discharged
home.
At 7 wks of age, he was readmitted to the hospital with tachyp-
nea, hypoxia, and hypercapnia. On bronchoscopy, he was noted
to have ﬂoppy upper airways, laryngomalacia, tracheomalacia,
and bronchomalacia. His respiratory status worsened, and he
required intubation and eventually tracheotomy. Chest computed
tomography (CT) (Figure 1L) and X-ray (Figure 1M) showeder 13, 2009
Figure 1. Clinical Manifestations of
Patients with LTBP4 Mutations
(A–E) Characteristics of patient 1 at 1 mo
of age included (A and B) ﬂattenedmidface
with a wide nasal bridge, long philtrum,
micrognathia, swollen eyelids, receding
forehead and dolichocephaly, (C) redun-
dant skin on the trunk and (D) extremities,
and (E) widely spaced ﬁrst and second toes
with transverse plantar creases.
(F) X-ray imaging demonstrated dilated
intestines, laterally displaced liver, com-
pressed chest, and inguinal hernia.
(G) Upper gastrointestinal imaging high-
lighted esophageal tortuosity.
(H) Contrast imaging of the bladder
showed severe diverticulosis.
(I–K) Clinical pictures of patient 2 at 2 mo
of age showed (I) craniofacial features
similar to patient 1, as well as (J and K)
cutis laxa.
(L) CT image at 3 mo showing hyperinﬂa-
tion of the anterior and atelectasis of the
posterior lung.
(M) X-ray image showing bell-shaped
chest, atelectasis of the right lung, and
hyperinﬂation of the left lung.
(N) Severe bladder diverticulosis.
(O and P) Clinical photographs of Patient
3 taken at 3 yrs 1 mo illustrate cutis
laxa with premature aged appearance
throughout the body, including (O) the
legs and (P) the abdomen. The patient
also had a gastrostomy tube and tracheos-
tomy.
(Q) Chest CT image of parasternal dia-
phragmatic hernia with cystic changes
and atelectasis of the lung at 3 yrs 6 mo
of age.
(R) Upper gastrointestinal contrast image
showing stomach diverticula at 3 yrs
6 mo of age.
(S) Urinary tract contrast imaging showing
bladder diverticula at 2 yrs 4 mo of age.hyperinﬂation with areas of atelectasis and cystic change. He
showed poor weight gain, and both weight and length fell below
the 3rd percentile when he was 2 mo of age, despite his being on
high-calorie formula. A gastrostomy tube was placed for prolonged
enteral feeding. Bilateral inguinal hernias were also observed, and
additional imaging demonstrated tortuous vessels, including the
internal jugular veins and inferior vena cava.
Despite positive and negative pressure ventilation, the patient
continued to have difﬁculty with both oxygenation and ventila-
tion. His respiratory function worsened, and he died at 4 mo.
At autopsy, the right upper lobe of the lung was hyperinﬂated
and extended into the left superior anterior hemithorax. The
remainder of the lungs showed mixed areas of hyperinﬂation
and atelectasis. The bronchial tree showed situs ambiguous with
bilateral left-sided architecture. Multiple urinary bladder diver-
ticula, bilateral congested renal cortices, mild left hydronephrosis,
and bilateral adrenal hypoplasia were observed. The peritoneal
cavity contained 510 ml ascites. The ascending colon had diver-The Americanticula, and the ileocecal junction lacked the valve and was dilated.
Osteopenia, thymic hypolasia and left sided accessory spleen
(1 cm) were found.
Patient 3
Patient 3 was born to ﬁrst-cousin parents (Figure 2E) of Palestinian
ancestry, by spontaneous vaginal delivery. Birth length, weight,
and head circumference were at the 10th–25th, 2nd, and 5th percen-
tiles, respectively. The patient had respiratory distress at birth, and
chest X-ray was suspicious for congenital diaphragmatic hernia.
Exploratory laparotomy revealed a paraesophageal hernia, gastric
strangulation, and the presence of a transverse colon in the chest.
Reduction and repair of the defect were performed. Other neonatal
ﬁndings included excessive skin laxity, bladder diverticula
(Figure 1S), prolapse of the urethra and cervix, and pelvic ﬂoor
herniation. Voiding cystourethrogram demonstrated spontaneous
voiding without reﬂux or obstruction. The patient was dischargedJournal of Human Genetics 85, 593–605, November 13, 2009 595
Figure 2. Mutations Found in LTBP4
(A) The parents of patient 1 were second cousins.
(B) DNA sequencing showed that patient 1 (V.1) was homozygous for mutation p.Q1185fsX1211, whereas his unaffected father (Fa) and
mother (Mo) were both heterozygous.
(C) The parents of patient 2 were unaffected and unrelated.
(D) Patient 2 (II.1) was compound heterozygous for mutation p.P264fsX300 inherited from his mother (Mo) and mutation p.C857X
inherited from his father (Fa).
(E) Patient 3 was an offspring of ﬁrst-cousin parents.
(F) Homozygous mutation p.C274G (arrowhead) in patient 3 (IV.1) compared to normal sequence in a control individual (Co).
(G) The pedigree of patient 4.
(H) Patient 4 (II.1) was compound heterozygous for mutations p.C857X and p.P1376fsX1403. Neither of these mutations was found in
his mother (Mo), suggesting that at least one of the mutations was de novo. No DNA sample was available from the father.
(I) The cysteine residue replaced by the mutation p.C274G found in patient 3 is highly conserved in all vertebrates.
(J) Schematic representation of the domain structure of LTBP4, showing the location of the mutations.but was subsequently admitted at the age of 4 wks as a result of
respiratory distress and was placed on an apnea monitor.
At 6 wks of age, the patient was intubated as a result of apnea,
respiratory distress, and a right upper lobe inﬁltrate. A barium
study showed evidence for gastresophageal reﬂux. Laparoscopic
Nissen fundoplication and gastrostomy tube placement were per-
formed. Because of ongoing respiratory problems, the patient
eventually underwent tracheostomy. She receives bilevel positive
airway pressure (BiPAP) ventilation and supplemental oxygen at
night. A CT scan at 3.5 yrs showed Morgagni (parasternal) dia-
phragmatic hernia (Figure 1Q). Upper gastrointestinal contrast
imaging showed severe diverticulosis of the stomach (Figure 1R).
She did not start walking until after 3 yrs of age. At 7 yrs of age,
she walks but fatigues easily and has difﬁculty jumping or
running. She uses a speaking valve and can say about 70–80 words
and form short, complete sentences. She is in kindergarten, can
count to 17, and knows her letters, shapes, and colors. The phys-
ical exam is signiﬁcant for generalized cutis laxa (Figures 1O and
1P), inverted V-shaped eyebrows, long philtrum, and a premature
aged appearance.596 The American Journal of Human Genetics 85, 593–605, NovembPatient 4
Patient 4 was born to unaffected and unrelated parents
(Figure 2G), at 38 wks gestation, by vertex vaginal delivery.
Length, weight, and head circumference were at the >90th, 75th,
and 40th percentiles, respectively. Apgar scores were 8 and 9. Respi-
ratory status was initially normal, but oxygen saturations of 80%–
90% prompted transfer to the neonatal intensive care unit. Mild
respiratory distress ensued, necessitating oxygen, which was
weaned over a 2–3 day period, consistent with transient tachyp-
nea of the newborn.
Genetics was consulted on day 4 of life, for hypotonia, poor
feeding, and skin laxity. The family history was noteworthy for
several individuals on the maternal side with skin laxity at birth,
which subsequently improved, resolving by adulthood. Therefore,
a dominant form of cutis laxa was initially suspected. There was
also a history of congenital heart disease, one maternal aunt dying
from a ‘‘three-chambered heart’’ at 2 wks of age and a second aunt
having heart disease that was surgically repaired. Two maternal
aunts also had a history of large abdominal-wall defects with
extrusion of abdominal contents. Despite a positive maternaler 13, 2009
family history, the mother did not carry any of the mutations
found in patient 4 (Figure 2H). Thus, we concluded that the birth
defects in maternal relatives were unrelated to the LTBP4 muta-
tions found in the patient.
Physical examination revealed a mildly dysmorphic child with
retrognathia, umbilical hernia, widely spaced ﬁrst and second
toes, and a unilateral transverse palmar crease. Loose skin that
could be easily pulled 3–4 cm from the underlying surface was
evident on the abdomen, legs, and thighs. Chromosomal analysis,
methylation studies for Prader-Willi syndrome, echocardiogram,
electrocardiogram, and magnetic resonance imaging of the brain
were all normal.
Vomiting during the ﬁrst 2 wks prompted an evaluation for
obstruction, which revealed pyloric stenosis, leading to pyloro-
myotomy. The patient was discharged at 6 wks of age after the
feeding problems resolved.
The patient was subsequently hospitalized because of respira-
tory distress at 3 mo of age and was found to have viral pneu-
monia, a right-sided Bochdalek diaphragmatic hernia, and rectal
prolapse. During a complicated hospital course, which included
a long stay in the intensive care unit, she had a variety of problems
and procedures, including rhinovirus, parainﬂuenza pneumonia,
pulmonary hypertension, and surgical repair of the diaphragmatic
hernia, umbilical hernia, and rectal prolapse. A gastrostomy tube
was placed for nutrition and medications. Given her tracheomala-
cia, a tracheostomy was recommended. However, because of her
poor prognosis, the family opted for ‘‘do not resuscitate’’ status
and hospice care, and she was discharged with ongoing oxygen
supplementation through a nasal cannula.
Physical examinationwhen the patient was 7mo of age revealed
a weight of 5.3 kg (< 3rd percentile) and a length of 64 cm (8th
percentile). She exhibited markedly increased skin laxity, with
redundant skin that could easily be stretched 4–5 cm from the
surface hanging from her face and other areas of her body. Her
abdomen was protuberant, but soft. The joints were mildly hyper-
extensible. The patient was stable until age 23 mo, when she died
suddenly at home after an acute aspiration event.
Mutational Analysis
Peripheral blood or cultured skin ﬁbroblasts were used as a source
of DNA. Samples from the probands were subjected to mutational
analysis of the entire coding region of LTBP4 and ﬂanking noncod-
ing sequences. Intron-derived primers for PCR ampliﬁcation of all
35 LTBP4 exons were synthesized with the use of sequence infor-
mation obtained from the reference sequence (GenBank accession
number NT_011109). Intron and exon boundaries were deduced
from information available in the database and by comparison
with the LTBP4 cDNA isoforms (NM_001042544, NM_003573,
NM_001042545). Primers were designed with the Vector NTI
Advance program, version 9.1, on the basis of the annotated
genomic sequence across each exon, including regions of at least
80–100 bp of ﬂanking intervening sequence (primer sequences
available upon request). PCR ampliﬁcations were performed in
a 25 ml volume with 100 ng of genomic DNA, 25 mM of each
primer, 200 mM dNTPs, 1 M betaine, optimized KTLA buffer pH 9
or 7.9, and 0.05 U of KlenTaq LA DNA polymerase (DNA poly-
merase facility, Washington University, WA, USA). Exon 6 was
ampliﬁed with the use of platinum Pfx polymerase (Invitrogen,
Carlsbad, CA, USA). Standard PCR cycle conditions were per-
formed, and amplicons were visualized by agarose gel electropho-
resis. PCR products were treated with 2 U each of exonuclease I
and shrimp alkaline phosphatase (USB, Cleveland, OH, USA) forThe Americanthe removal of unincorporated dNTPs and excess primers. Puriﬁed
PCR-ampliﬁcation products were sequenced with BigDye Termi-
nator Chemistry and were electrophoresed on ABI 3730XL
(Applied Biosystems, Foster City, CA, USA). Sequence traces of
both the sense and the antisense strands of the PCR-ampliﬁed
fragments were compared with the reference gene sequences
with Sequencher 4.5 software (GeneCodes, Ann Arbor, MI, USA).
DNA sequencing of two independent ampliﬁcation products
conﬁrmed mutations in each case. The inheritance of mutations
was conﬁrmed by sequence analysis of parental DNA, if avail-
able. The numbering of mutant DNA positions was based on
NT_011109 (genomic DNA) and NM_003573 (cDNA).
RNA Expression Analysis
Fibroblasts were cultured to conﬂuence at passages 2–8 in Dulbec-
co’s modiﬁed Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), 25 mM HEPES, L-glutamine, and antibi-
otics. Parallel cultures were incubated with 100 mg/ml cyclohexi-
mide for study of nonsense-mediated decay. Conﬂuent cultures
were used for extraction of RNA with TRI-reagent (Molecular
Research Center, Cincinnati, OH, USA). Contaminating genomic
DNA was removed with the Turbo DNA-free Kit (Ambion, Austin,
TX, USA). First-strand cDNA was synthesized from total RNA
samples (1 mg each) with the use of SuperScript III reverse tran-
scriptase (Invitrogen). We performed reverse transcriptase-PCR
(RT-PCR) by using the cDNA templates to amplify desired regions
of LTBP4 for the determination of possible splicing changes caused
by nonsense and frameshift mutations. After visualization on
a 1.2% agarose gel, bands were puriﬁed with the QIAquick Gel
Extraction Kit (QIAGEN, Valencia, CA, USA) and were subjected
to direct sequencing. PCR primers were designed at least one
exon away from the mutation in question. Quantitative PCR
was performed with iQ SYBR Green Supermix and an iCycler iQ
PCR System (Bio-Rad, Hercules, CA, USA) for the measurement
of LTBP4 and TGFB1 (MIM 190180) expression. ACTB (b-actin
[MIM 102630]) was used as a reference transcript (primer
sequences available upon request). Experiments were performed
in triplicate. ‘‘No RT’’ samples were used as a PCR control measure
for gDNA contamination. We performed DCt analysis to assess
relative RNA expression levels, by ﬁrst calculating the difference
between the threshold cycle number (Ct) value of the target
gene (LTBP4, TGFB1) and the average Ct value of the correspond-
ing ACTB sample. We estimated relative mRNA abundance by
calculating 2DCt.
Immunoblotting
Cell cultures were washed with serum-free media and incubated
with fresh serum-free media for 24 hr. The conditioned media
(CM) were collected, and protease inhibitors were added. The
CM were clariﬁed by centrifugation and stored at –80C. Proteins
in conditioned media samples were separated by SDS-PAGE with
the use of 4%–20% gradient polyacrylamide mini gels and trans-
ferred to nitrocellulosemembranes by electroblotting. Membranes
were blocked in PBS/0.1% Tween-20 containing 5% nonfat milk
for 1 hr at room temperature and then incubated with primary
antibodies speciﬁc for LTBP-1 or LTBP-4 overnight at 4C. The
membranes were washed ﬁve times in PBS/0.1% Tween-20 and
incubated in the appropriate secondary antibody for 1 hr at
room temperature. After washing, the blots were developed by
chemiluminescence with the use of enhanced chemilumines-
cence (ECL) (Thermo Scientiﬁc, Waltham, MA, USA) detection
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Immunocytochemistry
For analysis of the expression of ECM proteins, cells were plated
on coverslips in 6-well plates and grown for at least 2 wks past
conﬂuence. Postconﬂuent cultures were washed once with PBS,
ﬁxed with 100% ethanol at room temperature for 10min, and pro-
cessed for standard indirect immunoﬂuorescence. Fixed cells were
washed three times in PBS and were blocked with 1% goat serum
in PBS for 1 hr at room temperature. Fibroblasts were stained for
double immunoﬂuorescence with the use of primary antibodies
against LTBP1 (Ab39) or LTBP4 (pAb2101) together with mAb69,
speciﬁc for FBN1. After three washes with PBS, the cells were incu-
bated with secondary antibodies: anti-mouse Alexa Fluor 488 and
anti-rabbit Alexa Fluor 594 (Invitrogen). Nuclei were stained with
DAPI. The coverslips were mounted on glass slides with Prolong
Gold anti-fading reagent (Invitrogen) and examined under the
Axioskop 2 Mot Plus imaging microscope (Zeiss, Thornwood,
NY, USA) with the use of a 403 objective. Images were acquired
with an AxioCam MRm camera (Zeiss) and AxioVision 3.1 soft-
ware (Zeiss).
TGF-b Activity Assay
Reporter mink lung epithelial cells (MLECs), which produce lucif-
erase in response to TGF-b, were used as previously described.21
MLECs and test cells were each suspended at 5 3 105/mL in
DMEM containing 2.5% FBS. MLECs were plated ﬁrst at 100 mL/
well (96-well plates), and 100 ml of test cell suspensions or DMEM
supplemented with 2.5% FBS were added. TGF-b signaling was in-
hibited by addition of the ALK5 inhibitor, SB431542 (Sigma, St.
Louis, MO, USA), to 5 mM ﬁnal concentration. Cells were cocul-
tured for 16–20 hr. Lysates were assayed for luciferase activity as
described previously.21 Experiments were repeated three times,
with similar results observed each time.
Histology
Skin tissue in parafﬁn blocks were cut to 5-mm-thick sections.
Sections were deparafﬁnized in Histo-Clear (National Diagnostics,
Atlanta, GA, USA) and rehydrated. All histological sections were
stained with hematoxylin-eosin. For elastic ﬁber staining, sections
were subjected to Hart’s elastin stain. In brief, sections were
immersed in 0.25% potassium permanganate solution for 5 min.
Slideswere cleared in 5%oxalic acid and soaked in resorcin-fuchsin
solution overnight. After washing in water, sections were counter-
stained with tartrazine (yellow), dehydrated in ethanol, cleared in
xylene, and mounted. Sections were viewed under bright-ﬁeld
optics with a BX60microscope (Olympus, Center Valley, PA, USA).
Electron Microscopy
Biopsies were ﬁxed in glutaraldehyde, stained sequentially with
OsO4, tannic acid, and uranyl acetate, dehydrated, and embedded
in Epon.22 Thin sections (60 nm) were cut, placed on formvar-
coated grids, and counterstained with 7% methanolic uranyl
acetate and lead citrate. Sections were viewed with a Tecnai 12
transmission electron microscope at 120 kV, and images were digi-
tally captured.
Statistical Analysis
Group means and standard errors of means were calculated for
continuous variables, including relative gene expression and
TGF-b activity data. Unpaired t tests for samples with unequal vari-
ance were used for investigating whether pairwise differences of
group means were signiﬁcant (p < 0.05).598 The American Journal of Human Genetics 85, 593–605, NovembResults
LTBP4 Mutations
While performing comparative electron microscopic anal-
ysis of tissue samples from human patients with connec-
tive tissue diseases and from mice lacking the short form
of Ltbp4 (Ltbp4S), we noted that these mice showed elastic
ﬁber pathology that was strikingly similar to that of a
patient (patient 1) who had cutis laxa with lethal pulmo-
nary complications and gastrointestinal and urinary
involvement. Moreover, Ltbp4S/ mice also developed
severe pulmonary and gastrointestinal disease,23,24 similar
to patient 1. Therefore, we reasoned that patient 1 might
have an alteration in LTBP4. We sequenced all exons of
LTBP4, and we identiﬁed a homozygous mutation,
p.Q1185fsX1211, in patient 1 (Figure 2B).
To match the phenotype of patient 1, we selected nine
probands from a cohort of 100 probands with cutis laxa
on the basis of the presence of severe pulmonary, gastroin-
testinal, and urinary involvement. Mutational analysis of
LTBP4 and detailed clinical follow up remains incomplete
in four of the nine patients. Thus, these four patients were
removed from the study. Of the remaining ﬁve patients,
three (patients 2–4) were positive and two were negative
for LTBP4mutations. Patients 1–4 had either homozygous
or compound heterozygous mutations. Each homozygous
patient was an offspring of a consanguineous union
(Figures 2A and 2E). Patients 1 and 2 inherited one muta-
tion from each parent. In contrast, the mother of patient
4 was negative for both of the mutations found in the
patient, indicating that at least one of the mutations was
de novo.
Four of the ﬁve identiﬁed mutations (Figure 2, Table 1)
were predicted to lead to premature termination
codons (p.P264fsX300, p.C857X, p.Q1185fsX1211, and
p.P1376fsX1403), whereas one replaced a highly con-
served cysteine in the hybrid domain of LTBP4 with
glycine (p.C274G; Figures 2I and 2J). Interestingly, four
of the ﬁve mutations were located in either a hybrid or
an 8-cysteine domain, domains known to have long-range
effects on ﬁbrillin and LTBP conformation.25,26
Patients 2, 3, and 4haveundergone extensivemutational
screening of known cutis laxa genes FBLN5 and FBLN4
(EFEMP2) and of candidate genes FBLN1 (MIM 135820),
FBLN2 (MIM 135821), FBLN3 (EFEMP1 [MIM 601548]),
SLC2A10 (GLUT10), LOX (MIM 153455), LOXL1 (MIM
153456), and LOXL2 (MIM 606663), all with negative
results. FBLN5mutations were also excluded in patient 1.
Clinical Features
The shared clinical characteristics among the patients
positive for LTBP4 mutations are summarized in Figure 1
and Table 2. Craniofacial features included receding fore-
head, microretrognathia, wide fontanelles, periorbital
swelling, hypertelorism, ﬂat midface, and wide nasal
bridge. Patients had severe infantile bronchopulmonary
dysplasia with developmental emphysema, cystic, ander 13, 2009
Table 1. LTBP4 Mutations
Patient Ethnicity Exon Domain Status Gene cDNA Protein
1 Hispanic 28 8-CYS 2 hom g.29481delA c.3554delA p.Q1185fsX1211
2 Mexican 9 HYB het g.12574 c.791delC P264fsX300
22 EG 11 het g.25287_25288delGCinsAA c.2570_2571delGCinsAA p.C857X
3 Palestinian 9 HYB hom g.12603T>G c.820T>G p.C274G
4 Hispanic 22 EG 11 het g.20287_20288delGCinsAA c.2570_2571delGCinsAA p.C857X
33 8-CYS 3 het g.33861insC c.4128insC p.P1376fsX1403
Abbreviations are as follows: EG, EGF-like domain; HYB, hybrid domain; 8-CYS, 8-cysteine domain; het, heterozygous; hom, homozygous.atelectatic abnormalities, hypoplastic lungs, and suscepti-
bility to pneumonia. Respiratory lesions were complicated
by laryngomalacia, tracheomalacia, bronchomalacia, dia-
phragmatic hernia, and pulmonary hypertension with
vascular stenoses at various levels of the pulmonary
vessels. Three patients died of respiratory failure in infancy
or in early childhood. Gastrointestinal anomalies included
tortuosity, diverticulosis, and dilation of the digestive tract,
pyloric stenosis, and umbilical hernias. Genitourinarymal-
formations were severe, with bladder diverticulosis and
hydronephrosis and inguinal hernias. Musculoskeletal
abnormalities included joint laxity, muscle weakness,
and widely spaced ﬁrst and second toes with plantar
creases. All patients had loose, redundant, and inelastic
skin. Postnatal growth was impaired.
The two patients who were negative for LTBP4 muta-
tions had dermal, pulmonary, gastrointestinal, and urinary
lesions similar to those of mutation-positive individuals.
However, one of themutation-negative patients had severe
enlargement of the aortic root, a lesion not observed
among mutation-positive subjects.
Reduced Synthesis, Secretion, and Extracellular
Deposition of LTBP4
We assessed the effect of mutations on LTBP4 biosynthesis
by using skin ﬁbroblasts from patients 1, 2, and 4, whose
mutations were predicted to lead to premature termination
codons. Fibroblasts were not available from patient 3, who
was homozygous for missense mutation p.C274G. Quanti-
tative RT-PCR analysis showed greatly reduced LTBP4
expression in each patient sample (5% of normal levels
on average), suggesting that the premature termination
mutations led to the destabilization of the mRNA via the
nonsense-mediated decay pathway (Figure 3A). TGF-b1
mRNA levels were unaltered in the patient ﬁbroblasts
(Figure 3A).
Exons 28 and 29 encode the second 8-cysteine domain,
which interacts with latent TGF-b1. However, in some
tissues, these two exons can be spliced out, yielding an
LTBP4 isoformunable to bind latent TGF-b127. This isoform
(del 28,29) is abundantly expressed in skin ﬁbroblasts.
Because the mutation in patient 1, p.Q1185fsX1211, was
located in exon 28 and was predicted to cause prematureThe Americantermination in exon 29, we studied the splicing of these
exons in patient and control ﬁbroblasts. The expression of
the full-length (FL)LTBP4 isoformwas signiﬁcantly reduced
inpatient 1 in comparison to that observed ina control (Fig-
ure 3B). Treatment with cycloheximide, an inhibitor of
nonsense-mediated decay, partially rescued the expression
of FL LTBP4, providing evidence for mutation-induced
destabilization of this isoform in patient 1 (Figure 3B).
Consistent with reduced mRNA levels, conditioned media
from patient 1 ﬁbroblasts contained diminished amounts
of LTBP4 but normal levels of LTBP1 (Figure 3C).
LTBP4 targets latent TGF-b to ﬁbronectin and ﬁbrillin-1
(FBN1)-containing microﬁbrils.28 Therefore, we examined
the ability of patient ﬁbroblasts to incorporate LTBP4
into the ECM. Whereas control ﬁbroblasts showed strong
colocalization of FBN1 and LTBP4, FBN1 microﬁbrils
lacked LTBP4 in the ECM of cells from patient 1 (Fig-
ure 3D). In contrast, LTBP1 was efﬁciently incorporated
into FBN1 microﬁbrils in both patient and control cells
(Figure 3D). Given the signiﬁcant reduction in LTBP4
expression at the mRNA level, we expect that incorpora-
tion of LTBP4 into the ECM is also severely impaired in
patients 2 and 4.
Increased TGF-b Activation
To investigate the effect of LTBP4 mutations on latent
TGF-b activation and signaling, we cocultured TGF-b
reporter cells with ﬁbroblasts from patients 1, 2, and 4
and from two controls. Patient cells produced signiﬁcantly
higher levels of active TGF-b than did control cells. TGF-b
activity was greatly reduced by a chemical inhibitor
(SB431542) of the TGF-b receptor I kinase (Figure 3E).
However, TGF-b1mRNA levels were normal in the patients
(Figure 3A), suggesting that the release and/or storage, but
not synthesis, of TGF-b were abnormal in LTBP4-deﬁcient
cells. Thus, loss of LTBP4 causes increased active TGF-b by
altering TGF-b bioavailability in the ECM.
Abnormal Elastic Fiber Formation
Previous studies of Ltbp4S/mice23,24 revealed signiﬁcant
disruption of elastic ﬁbers in multiple tissues (Figure 4M).
Therefore, we investigated the distribution and mor-
phology of elastic ﬁbers and the overall histopathology ofJournal of Human Genetics 85, 593–605, November 13, 2009 599
Table 2. Clinical Features Associated with LTBP4 Mutations
Patient 1 Patient 2 Patient 3 Patient 4
Skin
Cutis laxa þ þ þ þ
Craniofacial
Long philtrum þ þ þ ?
Flat midface þ þ þ ?
Receding forehead þ þ ? þ
Periorbital swelling þ þ ? ?
Hypertelorism þ þ ? ?
Wide nasal bridge þ þ ? ?
Retrognathia,
micrognathia,
or mandibular
hypoplasia
þ þ þ þ
Wide sutures or
fontanelles
þ þ ? 
Pulmonary
Tachypnea, respiratory
distress
þ þ þ þ
Tracheal tube  þ þ 
(declined)
Lanryngo-, tracheo-,
or bronchomalacia
 þ ? þ
Emphysema or
hypoplastic lung
þ þ (1) ? þ (1)
Diaphragmatic hernia
or eventration
 þ (2) 23 (3, 4) þ (5)
Pneumonia þ   þ
Cardiovascular
Pulmonary artery
stenosis
þ (6)  ? þ (7)
Patent foramen ovale þ þ  ?
Gastrointestinal
Gastro-esophageal
reﬂux
  þ þ
Diverticula  a. colon gastric ?
Gastric tube þ þ þ þ
Pyloric stenosis  þ  þ
Intestinal dilation,
tortuosity
þ (8) þ (9) ? 
Umbilical hernia þ   þ
Rectal prolapse   þ þ
Genitourinary
Bladder diverticula þ þ þ ?
Hydronephrosis þ (left) þ  ?
Inguinal hernia þ bilateral  
Musculoskeletal
Joint laxity þ þ þ þ600 The American Journal of Human Genetics 85, 593–605, Novemaffected organs in our patients. In control skin (Figure 4A),
elastic ﬁberswere robust inboth thedeep andupper dermis.
Conversely, in the skin of patients 1 (Figure 4B) and 2
(Figure 4C), the ﬁne candelabra-like elastic ﬁbers in the
upper dermis were missing. Also, dermal elastic ﬁbers were
fragmented and weakly stained and had less-deﬁned edges
in patients than in controls. Skin tissue was not available
from patients 3 and 4.
Histology of the lung revealed a severe septation defect in
patient 2 (Figure 4D). The parenchyma had a saccular
morphology, was devoid of alveoli, and showed extreme
airspace enlargement. The elastic ﬁbers were oriented
parallel to the sacculewalls, andoccasional focal concentra-
tions of elastic ﬁbers were found at locations resembling
failed alveolar septum formation. The capillaries were
enlarged and had thickened walls. No inﬂammation was
evident. Other areas contained collapsed parenchyma and
airways (Figure 4E). In the lamina propria of the tracheal
mucosa (Figure 4F) and submucosa (Figure 4G), the elastic
ﬁbers were discontinuous and fragmented, respectively.
The tunica media of the aorta showed focal discontinuities
(Figure 4H) and cystic changes (Figure 4I), and the internal
elastic lamina was fragmented (Figure 4J). Lung, trachea,
and aorta samples were not available from patients 1, 3,
and 4.
Electron microscopy of dermal elastic ﬁbers in con-
trol tissues showed typical elastic ﬁbers, with a core of
elastin surrounded by a peripheral mantle of microﬁbrils
Table 2. Continued
Patient 1 Patient 2 Patient 3 Patient 4
Low muscle tone þ þ ? þ
Widely spaced ﬁrst
and second toes
þ þ ? þ
Plantar crease þ þ ? 
Growth Delay
Prenatal   þ 
Postnatal þ þ þ þ
Survival
Age at death (mo) 9 4  26
Cause of death resp resp  resp
Lab
Ceruloplasmin
(mg/dL)
normal
(10)
13
(normal)
? ?
Copper (mg/L) normal 384 (low) ? normal
Chromosomes ? normal normal normal
Data are indicated as follows: þ, present; -, absent; ?, unknown; 23, recurrent;
a. colon, ascending colon; resp, respiratory; (1) hyperinflation, atelectasis,
cystic change; (2) eventration; (3) hiatal hernia; (4) Morgagni hernia; (5) Boch-
dalek hernia; (6) left, right, and peripheral pulmonary stenoses, right ventri-
cular hypertrophy; (7) pulmonary valve and infundibular stenosis, pulmonary
hypertension; (8) tortuous duodenum; (9) dilated ileocecal junction, lacks
valve; (10) initially low.ber 13, 2009
Figure 3. Functional Consequences of LTBP4 Mutations In Vitro
(A) Quantitative RT-PCR analysis showed severely reduced expression of LTBP4 in skin ﬁbroblasts from three patients (1, 2, and 4) in
comparison to three controls, triplicates each. Results were normalized to b-actin (ACTB) and expressed as group averages5 standard
errors of means. The expression of TGF-b1 (TGFB1) was not altered signiﬁcantly (NS) in patients.
(B) Patient 1 (P1) expressed low levels of full-length (FL) LTBP4 in comparison to control (Co) ﬁbroblasts. Cycloheximide (CHX) treat-
ment (þ) partially rescued the expression of the FL isoform. Del 28,29 shows the exon 28, 29 skipping product, HD indicates a hetero-
duplex.
(C) Immunoblotting conﬁrmed severely reduced LTBP4 levels in conditioned media of ﬁbroblasts from patient 1 (P1). LTBP1 secretion
was normal in both control (Co) and patient ﬁbroblasts.
(D) Dual immunostaining in patient 1 (P1) shows an abundant ﬁbrillin-1 (FBN1, green) network but very little staining for LTBP4 (red).
Control cells (Co) show strong colocalization of FBN1 and LTBP4 (yellow, orange). LTBP1 (green) and FBN1 (red) were strongly colocal-
ized in both patient and control cells. Nuclei were counterstained with DAPI (blue). Magniﬁcation bars represent 50 mm.
(E) Measurement of TGF-b signaling by coculturing of reporter cells with ﬁbroblasts from patients 1, 2, and 4 (P, triplicates each) or two
controls (Co, six replicates each). Negative controls (None, six replicates) were reporter cells only. The presence of TGF-b receptor inhib-
itor (TGFBR Inh) is shown by a þ sign and absence by a  sign. Luminescence units were converted to TGF-b concentration with the use
of a TGF-b1 standard curve. Signiﬁcant difference is shown by a p value (t test) and error bars show standard errors of means.(Figure 4K). In contrast, elastic ﬁbers in patient 1 revealed
some elastin within the microﬁbril bundles but consider-
able elastin located external to thebundles in large, globular
deposits (Figure 4L), an appearance identical to that of
Ltbp4S/mice (Figure 4M). Skin samples ﬁxed for electron
microscopy were not available from patients 2, 3, and 4.
Discussion
Clinical and Diagnostic Considerations
To our knowledge, this is the ﬁrst description of a syndrome
characterized by craniofacial anomalies, severe pulmonaryThe Americanand visceral involvement, and skin laxity. Although some
clinical features of this syndrome overlap with several cutis
laxa syndromes, arterial tortuosity syndrome, Loeys-Dietz
syndrome, and Marfan syndrome (MFS), the constellation
of pulmonary, gastrointestinal, genitourinary, and dermal
lesions is a consistent and unique feature of the patients
reported here (Table 3). Because the multitude of speciﬁc
lesions associated with this syndrome makes it difﬁcult
to devise a descriptive name, we propose the name Urban-
Rifkin-Davis syndrome (URDS).
We recommend LTBP4 mutational screening in cutis
laxa patients with severe pulmonary, gastrointestinal,
and urinary abnormalities. On the basis of our currentJournal of Human Genetics 85, 593–605, November 13, 2009 601
Figure 4. Impaired Elastic Fiber and Tissue Architecture in
Patients with LTBP4 Mutations
(A) Hart’s elastin stain of the skin from a 9-mo-old control (Co)
shows robust, strongly stained horizontal elastic ﬁbers in the
deep dermis (arrowhead) and ﬁne candelabra-like vertical ﬁbers
in the papillary dermis (arrow).
(B and C) Skin sections from (B) patient 1 (P1) and (C) patient 2
(P2) lack elastic ﬁbers in the papillary dermis and have frag-
mented, diffuse ﬁbers in the deep dermis.
(D) Lung sections from patient 2 showed dramatically enlarged
(> 200 mm) saccular air spaces and rareﬁed elastic ﬁbers conﬁned
mostly to the saccular wall (black arrowheads) or to arrested septal
primordia (blue arrowheads). Capillaries were enlarged and had
thickened walls (arrows).
(E) Other areas of the lung contained collapsed air spaces (arrow-
head) and airways ﬁlled with proteinaceous exudates (arrows).
(F–J) Bronchi had (F) discontinuities (arrowheads) in the elastic
sheet of the lamina propria and (G) fragmented elastic ﬁbers in
the submucosa. Aortic sections from patient 2 showed overall
preserved vessel wall structure, but (H) discontinuities in elastic
lamellae (arrowheads), (I) cystic degeneration of the media (arrow-
heads), and (J) fragmentation of the internal elastic lamina (arrow-
heads) were observed.
(K) Electron microscopy of dermal elastic ﬁbers from a 7-mo-old
control (Co) showed robust insoluble elastin core (El) surrounded
by a ﬁne layer of microﬁbrils (Mf).
(L) In patient 1 (2 mo old), dermal elastic ﬁbers had a diminished
elastin core (El), with abundant microﬁbrils (Mf) and globular
elastin aggregates at the periphery of the ﬁber (Gl).
(M) Ultrastructural abnormalities of pulmonary elastic ﬁbers in
Ltbp4S/ mice were identical to those of patient 1.
Magniﬁcation bars represent 20 mm (A–C, G, J); 200 mm (D, E, H, I);
100 mm (F); 0.5 mm (L); and 0.2 mm (K, M).602 The American Journal of Human Genetics 85, 593–605, Novembexperience, we estimate the success rate of detecting LTBP4
mutations in this group of patients as approximately 67%.
Expansion of mutational screening to regulatory regions of
the LTBP4 gene, use of techniques that can detect dele-
tions, and electron microscopic detection of characteristic
dermal elastic ﬁber abnormalities prior to mutational anal-
ysis may further increase the success rate. The prevalence
of LTBP4 mutations in patients ascertained on the basis
of lethal alveolarization defects, severe diverticulosis or
intestinal dilatation, tortuosity, or stenoses will need to
be examined in future studies.
LTBP4 Function
Most LTBP4 mutations reported here were premature-
termination mutations, leading to severely reduced mRNA
abundance.Consistentwith this ﬁnding, a reduced amount
of secreted LTBP4 was found in the conditioned media of
mutant ﬁbroblasts. Thus, we conclude that reduced LTBP4
function is the primary cause of disease in this syndrome.
Ltbp4S/ mice develop pulmonary septation defects,
rectal prolapse, colorectal adenomas and carcinomas, and
dilated cardiomyopathy, but they survive up to 6 months
(mid-adult age) without major clinical symptoms.23,24
In contrast, patients with LTBP4 deﬁciency face high
mortality and respiratory failure in infancy or early
childhood. No cardiomyopathy or colorectal cancer was
observed in the patients, but these conditions may require
a longer time to develop. Patients had several lesions that
have not been reported in Ltbp4S/ mice, including
craniofacial and musculoskeletal features; gastrointestinal
stenoses, dilatation, and diverticulosis; bladder diverticu-
losis, and hydronephrosis. Overall, the milder phenotype
of the Ltbp4S/mice may be related to residual expression
of the long form of LTBP4 (Ltbp4L), not affected in this
mouse model.23,24 Species-speciﬁc functions of LTBP4 or
different amount of functional overlap with other LTBPs
in different species may also contribute to differences
in phenotypic outcomes of LTBP4 deﬁciency between
humans and mice.
LTBP4 deﬁciency leads to altered production of active
TGF-b and disorganization of elastic ﬁbers. The intimate
relationship between ECM integrity and TGF-b signaling
has been highlighted by recent studies on MFS, which is
caused by mutations in FBN1, encoding a major structural
protein of microﬁbrils. Administration of neutralizing
antibodies to TGF-b or treatment with the angiotensin II
type 1 receptor antagonist, losartan, prevent the develop-
ment of lung, aortic, and muscular abnormalities associ-
ated with MFS.19,29,30 Given the potential similarities
in disease mechanisms between MFS and the LTBP4-
deﬁciency syndrome described here, pharmacologic inter-
vention for normalization of TGF-b signaling may be a
treatment option.
LTBPs and Human Disease
The importance of LTBPs in human development has
only begun to be understood. A new autosomal-recessiveer 13, 2009
Table 3. Clinical Characteristics in Comparison to Other Related Syndromes
Present Study ARCL1 (FBLN4) ARCL1 (FBLN5) ARCL2 ADCL ATS LDS MFS CCA
Skin laxity þþþ þþþ þþþ þþþ þþþ þþþ þ  
Lethal BPD þþþ þþ þþ      
GI malformations þþþ        
GU malformations þþþ        
Arterial tortuosity  þþ þþ   þþþ þþþ  
Aortic aneurysm  þþ   þ þ þþþ þþþ þ
Aortic stenosis   þþþ      
Pulmonary artery stenosis þþ þþ þ  þ þþ þþ  
Microretrognathia þþþ     þþþ þþ  
Hypertelorism þþ     þ þþþ  
Wide fontanelles þþ   þþþ     
Microcephaly    þþþ     
Long philtrum þþþ þþþ þþþ þþþ þþþ    
Cleft palate, biﬁd uvula      þþ þþþ  þ
Joint laxity þþ þþþ  þþþ þ þþþ þþþ þþþ 
Joint contractures      þþ þþ  þþþ
Arachnodactily  þþ    þ þþ þþþ þþþ
Developmental delay, MR    þþþ   þ  
Postnatal growth delay þþþ þ þ þþ     
Abbreviations are as follows: ARCL1, autosomal-recessive cutis laxa type 1; FBLN4, fibulin-4; FBLN5, fibulin-5; ARCL2, autosomal-recessive cutis laxa type 2; ADCL,
autosomal-dominant cutis laxa; ATS, arterial tortuosity syndrome; BPD, bronchopulmonary dysplasia; LDS, Loeys-Dietz syndrome; MFS; Marfan syndrome; CCA,
congenital contractural arachnodactily; GU, genito-urinary; MR, mental retardation.
Symbols are as follows: þþþ, typical; þþ, common; þ, present; , absent.
Data are based on the following studies: ARCL1 (FBLN4),13,14 ARCL1 (FBLN5),15–17 ARCL2,33 ADCL,5–9 ATS,20 LDS,34 MFS,34 CCA.35form of oligodontia, associated with short stature,
increased bone density, and scoliosis, has been reported
in a family with an LTBP3 mutation.31 Another recent
report described recessive LTBP2 mutations in primary
congenital glaucoma associated with extopia lentis and
osteopenia.32 Thus, LTBP2 is essential for normal ocular
development, whereas LTBP3 is required for tooth forma-
tion and bone remodeling. We now show that LTBP4 is
necessary for the development of human visceral organs,
including the lung, intestines, and urinary tract. Among
the known LTBP-deﬁciency syndromes, mutations in
LTBP4 result in the most severe human disease described
to date.
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